DaVita Inc (DVA) FinancialsDVADaVita Inc

DaVita Inc (DVA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Patient service - Medicare and Medicare Advantage, accounting for 49.2% of total sales, equivalent to $1.75B. Other significant revenue streams include Patient service - Commercial and Patient service - Other government. Understanding this composition is critical for investors evaluating how DVA navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, DaVita Inc maintains a gross margin of 27.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.06%, while the net margin is 9.66%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively DVA converts its operational activities into shareholder value.

In the context of the broader market, DVA competes directly with industry leaders such as BTSG and EHC. With a market capitalization of $11.41B, it holds a significant position in the sector. When comparing efficiency, DVA's gross margin of 27.98% stands against BTSG's 12.72% and EHC's 90.20%. Such benchmarking helps identify whether DaVita Inc is trading at a premium or discount relative to its financial performance.

DaVita's revenue has increased from $11.6 billion to $13.6 billion over the past four years, with Q2 2026 revenue reported at $3.55 billion, showing consistent growth. The net income for Q2 2026 was $265.4 million, reflecting a strong profit margin of 9.66%.